April19 is a drug development company that integrates AI with computational chemistry to design and develop psychedelic-inspired compounds for various therapeutic indications, including neurodegenerative disorders and healthy longevity. The company focuses on expanding the utility of psychedelics beyond mental health by optimizing their pharmacology.

April19 Discovery

April19 Discovery Inc

April19 Discovery | 552 followers on LinkedIn. AI-driven psychedelic drug discovery | We use next-gen machine learning to find novel psychedelic drug compounds. Classical (first-generation) psychedelics have never been optimized to treat any disease and so we aim to design compounds with the optimal risk-benefit ratio in various indications. Beyond mental health, we focus on neurodegeneration and neural injuries, increasing brain longevity and extending human mental healthspan.

AI-driven drug discovery

Richard Dallaway

I give business owners more hours in the day - by outsourcing your business support to me creating time for YOU to smash those goals. Concierge |…

Jill Hartery

Founder & Business Lawyer at Britannia Law Corporation

Miles Gelmon

Ten years of cognitive decline reversed, cognitive scores increased by 57%, Alzheimer's diagnosis formally retracted... What a magnificent display of the power of psychedelics in treating neurodegenerative disorders. We are feeling truly blessed to see this hands-on confirmation that our development efforts are going very much in the right direction. We thank Chelsea R. and Cody Shirk from Spannr - End-to-End Longevity. who had wisely seen the potential of the compounds we are pursuing for treating neurodegeneration and advancing the quest for healthy longevity. And of course, Adam Tapp , the hero of this story, and of our time. Alzheimer's Society Alzheimer's Association® Mapping Alzheimer's Alzheimer's Readiness Project Alzheimer's Disease Research Alzheimer Nederland Alzheimer Society of Ireland Alzheimer's Association WNY Chapter Events Alzheimer's Products Australia American Alzheimer's Research Organization Alzheimer's Family Center Alzheimer's Drug Discovery Foundation Alzheimer's Care Specialists Alzheimer Society of Canada Société Alzheimer D. Alzheimers Family Organization #drugdiscovery #drugdevelopment #Alzheimer #neurodegeneration # #development #longevity #lifespan

Watch our CEO's lecture on using psychedelics in dementia treatment! (currently Czech only - comment if interested in English subtitles) #psychedelics #dementia #longevity #neurodegeneration #psychedelictherapy #Alzheimers

To our Czech followers - do not miss April19 CEO Jáchym Fibír giving a lecture about the development of revolutionary #psychedelic therapies for #neurodegeneration and #dementia at the Faculty of Philosophy, Charles University in Prague!

APRI

AI:APRIL19

April19 Discovery Inc

locale

market

industry

website

linkedin

peer of

competitor of

Metrics